SANA - Sana Biotechnology to Present at November and December 2023 Investor Conferences | Benzinga
SEATTLE, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in November and December. The presentations will feature a business overview and update.
- Sana will present at the 6th Annual Evercore ISI HealthCONx Conference at 1:20 p.m. ET on Wednesday, November 29, 2023.
- Sana will present at the JMP Securities Hematology and Oncology Summit at 2:00 p.m. ET on Wednesday, December 6, 2023.
The webcasts will be accessible on the Investor Relations page of Sana's website at https://sana.com/. A replay of each presentation will be available at the same location for 30 days following the corresponding conference.
About Sana Biotechnology
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people ...